Template:HIV CD4 Chart: Difference between revisions
No edit summary |
|||
| Line 7: | Line 7: | ||
| >500||Early disease||*Similar to nonimmunocompromised patients *Consider HAART medication side-effects | | >500||Early disease||*Similar to nonimmunocompromised patients *Consider HAART medication side-effects | ||
|- | |- | ||
| 200-500||Intermediate disease||[[ | | 200-500||Intermediate disease||[[Karposi sarcoma]], [[Candida]], bacterial respiratory infections | ||
|- | |- | ||
| <200||Late disease||[[PCP]], central line infection, [[MAC]], [[TB]], [[CMV]], [[drug fever]], [[sinusitis]], [[endocarditis]], [[lymphoma]], [[ | | <200||Late disease||[[PCP]], central line infection, [[MAC]], [[TB]], [[CMV]], [[drug fever]], [[sinusitis]], [[endocarditis]], [[lymphoma]], [[histoplasmosis]], [[cryptococcus]], [[PML]] | ||
|- | |- | ||
| <100||Very late disease||[[Cryptococcus]], [[Cryptosporidium]], [[Toxoplasmosis]] | | <100||Very late disease||[[Cryptococcus]], [[Cryptosporidium]], [[Toxoplasmosis]] | ||
Revision as of 04:34, 3 August 2015
HIV Associated Diseases by CD4 Level
| CD4 Count | Stage | Diseases |
| >500 | Early disease | *Similar to nonimmunocompromised patients *Consider HAART medication side-effects |
| 200-500 | Intermediate disease | Karposi sarcoma, Candida, bacterial respiratory infections |
| <200 | Late disease | PCP, central line infection, MAC, TB, CMV, drug fever, sinusitis, endocarditis, lymphoma, histoplasmosis, cryptococcus, PML |
| <100 | Very late disease | Cryptococcus, Cryptosporidium, Toxoplasmosis |
| <50 | Final Stage | CMV retinitis, MAC |
